Literature DB >> 29862192

Short and long-term outcomes of angle supported phakic intraocular lens implantation in high myopic eyes.

Saeed Al-Qahtani1, Khalid Al-Afraj2, Mohanna Al-Jindan2, Ali S Al-Beshri3, Rajiv Khandekar3.   

Abstract

This cohort study included 36 eyes of 21 patients with high myopia treated with angle supported phakic intraocular lens (pIOL). Endothelial cell density (ECD) at baseline, 6mo and 3y were 3017±296, 2775±265 and 2558±299 cells/mm2 respectively. ECD loss at 6mo was 7.2% and annual ECD loss was 3% over 36mo. Corrected distance visual acuity at 36mo was 0.4 logMAR or better in 32 (88.9%) eyes. Intraocular pressure did not change (P=0.9). No eyes developed cataract, retinal detachment or pupillary distortion. Angle supported pIOL gives good visual outcome. Endothelial cell loss should be monitored.

Entities:  

Keywords:  high myopia; phakic intraocular lens; refractive surgery

Year:  2018        PMID: 29862192      PMCID: PMC5957045          DOI: 10.18240/ijo.2018.05.27

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  15 in total

1.  AcrySof phakic angle-supported intraocular lens for the correction of high to extremely high myopia: one-year follow-up results.

Authors:  Rui-Bo Yang; Shao-Zhen Zhao
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 2.  Phakic intraocular lenses.

Authors:  Daniel H Chang; Elizabeth A Davis
Journal:  Curr Opin Ophthalmol       Date:  2006-02       Impact factor: 3.761

3.  AcrySof phakic angle-supported intraocular lens for the correction of moderate-to-high myopia: one-year results of a multicenter European study.

Authors:  Thomas Kohnen; Michael C Knorz; Béatrice Cochener; Ralf H Gerl; Jean-Louis Arné; Joseph Colin; Jorge L Alió; Roberto Bellucci; Antonio Marinho
Journal:  Ophthalmology       Date:  2009-05-30       Impact factor: 12.079

Review 4.  Phakic intraocular lens implantation for the correction of myopia: a report by the American Academy of Ophthalmology.

Authors:  David Huang; Steven C Schallhorn; Alan Sugar; Ayad A Farjo; Parag A Majmudar; William B Trattler; David J Tanzer
Journal:  Ophthalmology       Date:  2009-11       Impact factor: 12.079

5.  Myopic angle-supported intraocular lenses: two-year follow-up.

Authors:  N Allemann; W Chamon; H M Tanaka; E S Mori; M Campos; P Schor; G Baïkoff
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

6.  Long-term visual and refractive outcomes following surface ablation techniques in a large population for myopia correction.

Authors:  Sadhana V Kulkarni; Tahra AlMahmoud; David Priest; Sabrina E J Taylor; George Mintsioulis; W Bruce Jackson
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-21       Impact factor: 4.799

Review 7.  Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia.

Authors:  Allon Barsam; Bruce D S Allan
Journal:  Cochrane Database Syst Rev       Date:  2014-06-17

8.  Three-year results of Artisan/Verisyse phakic intraocular lens implantation. Results of the United States Food And Drug Administration clinical trial.

Authors:  R Doyle Stulting; Maurice E John; Robert K Maloney; Kerry K Assil; Peter N Arrowsmith; Vance M Thompson
Journal:  Ophthalmology       Date:  2007-11-26       Impact factor: 12.079

9.  Evaluation of sterile uveitis after iris-fixated phakic intraocular lens implantation.

Authors:  Mohamadreza Sedaghat; Mehran Zarei-Ghanavati; Mohammad-Reza Ansari-Astaneh; Virag Patel; Shameema Sikder
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Apr-Jun

10.  Endothelial Cell Loss after Phacoemulsification according to Different Anterior Chamber Depths.

Authors:  Hyung Bin Hwang; Byul Lyu; Hye Bin Yim; Na Young Lee
Journal:  J Ophthalmol       Date:  2015-08-31       Impact factor: 1.909

View more
  1 in total

Review 1.  Phakic intraocular lenses: An overview.

Authors:  Soraya M R Jonker; Tos T J M Berendschot; Isabelle E Y Saelens; Noël J C Bauer; Rudy M M A Nuijts
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.